Fear of Failure and overcoming it #CTO2024 J Aaron Grantham JAG Dr. Bill Lombardi

#HeartFailure2024 🇲🇽🇲🇽🤓🫀

🇲🇽🇲🇽🫀🫀

EMPACT-MI trial shows no reduction in endpoint of HF hospitalization or all-cause mortality with empagliflozin vs. placebo in post-MI setting. Dr. Javed Butler and I discuss results of EMPACT-MI trial here

Beautiful deep dive discussion on #EMPACT_MI by Robert Mentz, MD #ACC24 So…would you use SGLT2i post MI? Javed Butler responds: If indication (HF, DM, CKD) go ahead and get started! If a revascularized STEMI pt & no other major issue, probably ok not to start in acute setting!

Such a privilege to learn some applied cardiac anatomy from Dr. José Ángel Cabrera during #PCHF module 4 at Brussels, incredible teacher and person. Zurich Heart House (ZHH) 🇲🇽

Honored, humbled and very excited to be selected as candidate for position of president-elect for the #HFA board elections! To all members, please don’t forget to vote for these fantastic people! escardio.org/Sub-specialty-… Here are my top six priorities....together we can make it

Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) nej.md/4coe9zv Editorial: Entering a New Era in Sleep-Apnea Treatment nej.md/3RBd13I #ADASciSessions

Really incredible work in JACC Journals on one-time lipid levels in young adults Look at HR for later ASCVD and events! So, what do we do about it?

Elevated #NatriureticPeptides and #troponins are strong predictors of #HF events, but ever wondered if these biomarkers predict worsening cardiac structure & function? We analyzed NT-proBNP, TnT and TnI in a/w serial echo in ~2000 👤 in #ARIC Just published in Circulation 🧵 /5

*Breaking* Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA 14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD novonordisk.com/content/nncorp…

Reconditioned pacemaker devices non inferior with regards to infection or malfunction compared to new devices when implanted in low and middle income countries. Dr. Crawford shares data from the The My Heart Your Heart (MHYH) Randomized Controlled Trial View it here:

MHYH: ♥️New vs reconditioned pacemakers in pts from low-income countries ♥️Similar infection rates ♥️No malfunctions or failures of pulse generators ♥️”A labor of love done by so many people” #AHA24 American Heart News American Heart Association #CardioTwitter #Cardiology

Giving the world good cardiovascular health is the best gift we can think of! That’s why we work all year, with you, to reduce the burden of cardiovascular disease. Thank you – our successes are only possible because of your involvement. ESC President, Thomas Lüscher, shares

Welcome to our 4/2 issue of #JACCCaseReports JACC Journals! See our articles with links below and our 7-minute video summary of the entire issue by our AE Syed Zaid, MD! jacc.org/journal/case-r… Full PDF here: jacc.org/doi/10.1016/S2…. A video summary on our YouTube playlist:

What really happens when patients stop GLP-1s like semaglutide or tirzepatide? A new systematic review & meta-analysis in Obesity Reviews has answers—and they’re critical for anyone treating obesity as a chronic disease. TLDR: "Discontinuation of GLP-1RA treatment leads to

Our latest article describing a novel “confocal” technique to map LA activation just published Journal of Electrocardiology Dr. José Ángel Cabrera Adrian Baranchuk MD FACC FRCPC FCCS FSIAC Edgar Carrizales

A recent editorial. Electrical storm associated with cardiac calcifications.